Skip to main content
. 2021 Jan 26;2021:8896055. doi: 10.1155/2021/8896055

Figure 4.

Figure 4

Percentage of CD14lowCD16+ at three (3) consecutive time points: before methylprednisolone treatment and after 6 weeks and after 12 weeks of the treatment. Statistical significance was found between the 1st time point (i.e., before the treatment) and the last time point (after 12 weeks of treatment) (p = 0.015), as evaluated by the ANOVA Friedman test and Wilcoxon matched-pair test. Data are presented as means ± standard deviation (SD).